April 3, 2023 02:20 PM EDT
Pharma
FDA+
Manufacturing

FDA re­veals clean­ing and test­ing is­sues at Glob­al Phar­ma In­di­an man­u­fac­tur­ing site

Tyler Patchen

News Reporter

Glob­al Phar­ma Health­care’s man­u­fac­tur­ing site in In­dia has been in­spect­ed by the FDA, re­veal­ing sev­er­al stark qual­i­ty is­sues.

The 14-page re­port …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times